Cochrane Corner

Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis

Orlandi, Richard MD
Hopkins, Clair DM, FRCS
Philpott, Carl MD, ChB, DLO
Rosenfeld, Richard M. MD, MPH

¹University of Utah, Salt Lake City, Utah, USA
²King’s Health Partners Clinical Academic Groups, King’s College, London, UK
³Norwich Medical School and James Paget University Hospital, Norwich, UK
⁴Department of Otolaryngology, State University of New York Downstate Medical Center, Brooklyn, New York, USA

Richard M. Rosenfeld, MD, MPH, SUNY Downstate Medical Center, 450 Clarkson Avenue, MSC 126, Brooklyn, NY 11203, USA. Email: [email protected]

Received October 10, 2016

Received in revised form October 13, 2016

Accepted November 2, 2016

Otolaryngology - Head & Neck Surgery 156(3):p 397-402, March 2017. | DOI: 10.1177/0194599816680605

The Cochrane Corner is a section in the journal that highlights systematic reviews relevant to otolaryngology–head and neck surgery, with invited commentary to aid clinical decision making. This installment features a pair of related Cochrane Reviews on intranasal steroids for chronic rhinosinusitis, which identify low- to moderate-quality evidence for a beneficial effect on overall symptoms, nasal congestion, and rhinorrhea. There is no evidence, however, to suggest superiority of any particular steroid preparation or drug delivery system. The related expert commentary should help clinicians make the best treatment decisions based on the studies and outcomes identified in these Cochrane Reviews.